NasdaqGS:HSICHealthcare
Henry Schein (HSIC) Is Up 5.4% After Reaffirming 2026 Guidance And Completing Major Buyback Program
In early May 2026, Henry Schein reported first-quarter 2026 sales of US$3,368 million, slightly lower net income of US$107 million versus a year earlier, reaffirmed its 2026 earnings guidance with expected total sales growth of about 3% to 5% over 2025, and disclosed completion of a multi-year share repurchase program totaling 43.30 million shares for roughly US$3.10 billion.
Management also highlighted strong recent momentum in the dental segment, ongoing cost-saving and AI initiatives...